Point of Care Decision Support Point of Care Blog

Use of Outcome Measurements: Warfarin, NOACs and How They Apply to MU and National Quality Measures

Part 2 in a 5 part series - Improving the Quality of Chronic Oral Anticoagulation with Evidence-Based Guidelines

The Center for Medicare and Medicaid Services (CMS) has identified  Time in Therapeutic Range (TTR) as a Meaningful Use goal, and highlights that TTR’s greater than 70% represent high quality warfarin care, TTR’s of 65-70% are considered acceptable warfarin care and TTR’s under 65% needs improvement. 

The National Quality Foundation has endorsed multiple quality measures for anticoagulation, which include both inpatient and outpatient measures.  The outpatient measures include monthly testing of INR values, more frequent testing of INR values of individuals taking interacting medications such as antibiotics, and implementation of measures to ensure that regular and frequent INR testing is done on patients using Coumadin. 

Read More

Topics: Anticoagulation, Meaningful Use, Warfarin, DOAC, Adverse Drug Events, NOAC, National Quality Measures, TTR

PCDS believes that the complexity of patient care can be captured in a clear and meaningful way, enabling informed decision-making throughout the coordination and management of care.  We believe that connecting the point of care team with actionable information promotes patient engagement, analytic approaches to best practices, and system-supported collaborative efforts that are vital to patient safety, ambulatory service, and value across diverse health systems.

Subscribe to Email Updates

Recent Posts